Clinical Trial Update: A Lactation Study in Women Receiving Treatment With Ozanimod [Phase 4]

View source ↗

Summary

A Phase 4 lactation study of ozanimod (Zeposia) in women receiving treatment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lactating Women, Breastfed Infants | Phase 4 | Status: WITHDRAWN